Remedium Lifecare Limited

539561

INE549S01036

Pharmaceuticals

End-of-day quote Bombay S.E. Other stock markets 18:00:00 2024-05-22 EDT			5-day change	1st Jan Change
78.2 ^INR	-2.19%		-4.58%	-22.02%

04-12	Remedium Lifecare Limited Announces Board Changes	CI
02-28	Remedium Lifecare Bags Export Order Worth INR1.69 Billion	MT

Remedium Lifecare Limited Receives Export Order from Pharmyka General Trading LLC

February 27, 2024 at 10:49 pm

Remedium Lifecare Limited announced that the Company has received Export order of INR 1690 million from PHARMYKA General TRADING LLC. Nature of contract: Supply of Pharmaceutical Chemical. Time period by which the contract is executed: April 2024 to March 2025.

Latest news about Remedium Lifecare Limited

Remedium Lifecare Limited Announces Board Changes	04-12	CI
Remedium Lifecare Bags Export Order Worth INR1.69 Billion	02-27	MT
Remedium Lifecare Limited Receives Export Order from Pharmyka General Trading LLC	02-27	CI

Chart Remedium Lifecare Limited

Duration

Period

More charts

Company Profile

Remedium Lifecare Limited is an India-based pharmaceutical company. The Company is aligned across two business verticals: Products and Services. The Products business comprises trading and sale of active pharmaceutical ingredients (APIs) and intermediates to innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets. It is engaged in the business of trading in advanced pharmaceutical intermediates, API's and other pharma products used, such as iso propyl alcohol, cyclohexane, di iso propyl amine, ethyl acetate, hydrazine hydrate, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride, sodium carbonate (soda ash), amino isophthalic acid, tellurium(IV) oxide, Grignard reagent, selenium metal powder and trimethyl sulfoxonium iodide (TMSI). It is involved with the manufacture of various APIs, such as atorvastatin calcium (Amorphous) and citalopram hydrochloride.

Sector

Pharmaceuticals

Calendar

2024-05-26 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
REMEDIUM LIFECARE LIMITED	-22.02%	96.78M
ELI LILLY AND COMPANY	+38.69%	723B
NOVO NORDISK A/S	+34.28%	595B
JOHNSON & JOHNSON	-4.49%	369B
MERCK & CO., INC.	+20.24%	332B
ABBVIE INC.	+2.12%	282B
ASTRAZENECA PLC	+17.02%	244B
NOVARTIS AG	+9.31%	208B
ROCHE HOLDING AG	-5.07%	205B
PFIZER, INC.	-0.35%	168B